TNFR2: Role in Cancer Immunology and Immunotherapy

Immune checkpoint inhibitors (ICIs), including anti-CTLA-4 (cytotoxic T lymphocyte antigen-4) and anti-PD-1/PD-L1 (programmed death-1/programmed death-ligand 1), represent a turning point in the cancer immunotherapy. However, only a minor fraction of patients could derive benefit from such therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Islam, Md Sahidul, Hu, Yuanjia, Chen, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071081/
https://www.ncbi.nlm.nih.gov/pubmed/33907692
http://dx.doi.org/10.2147/ITT.S255224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071081/
https://www.ncbi.nlm.nih.gov/pubmed/33907692
http://dx.doi.org/10.2147/ITT.S255224

Ejemplares similares